IDEXX Laboratories Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
IDEXX Laboratories, Inc. income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue4.303.903.663.373.222.712.412.21
Cost of Revenue1.641.521.471.361.331.140.510.97
Gross Profit2.662.382.192.001.891.571.901.24
Operating Expenses
Research & Development0.250.220.190.250.160.140.130.12
Selling, General & Administrative1.051.030.900.850.800.740.680.63
Operating Expenses1.301.251.091.110.960.880.810.75
Operating Income1.361.131.100.900.930.690.550.49
Other Income/Expense
Interest Income0.000.010.010.000.000.000.000.00
Interest Expense0.040.03-0.040.040.03-0.030.000.03
Other Income/Expense-0.04-0.02-0.02-0.02-0.02-0.02-0.020.00
Income
Income Before Tax1.321.111.060.860.900.660.520.46
Income Tax Expense0.260.220.220.180.160.080.090.08
Net Income1.060.890.850.680.740.580.430.38
Net Income - Continuous Operations1.060.890.850.680.740.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.000.00
EBITDA1.471.271.211.011.040.790.610.58
EBIT1.361.141.100.900.930.690.520.49
Depreciation & Amortization0.110.130.110.110.100.100.090.00
Earnings Per Share
Basic EPS13.0011.0010.008.009.007.005.004.00
Diluted EPS13.0011.0010.008.009.007.005.004.00
Basic Shares Outstanding0.080.080.080.080.090.090.090.09
Diluted Shares Outstanding0.080.080.080.080.090.090.090.09